All HALO Content

Halozyme Therapeutics, Inc (HALO) Leerink Partners Global Healthcare Conference

Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Corporate Conference

February 25, 20261 min read

Halozyme Therapeutics, Inc (HALO) TD Cowen 46th Annual Healthcare Conference

Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Corporate Conference

February 25, 20261 min read

Halozyme Therapeutics, Inc (HALO) Sec Form 10K

Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 10K

February 19, 20261 min read

Halozyme Therapeutics, Inc (HALO) Sec Form 8K

Halozyme Therapeutics, Inc (NASDAQ: HALO) Sec Form 8K

February 19, 20261 min read

Halozyme Therapeutics, Inc (HALO) Reiterates Strong 2026 Financial Guidance

Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Other Release

February 17, 20261 min read

Halozyme Therapeutics, Inc (HALO) Q4 2025 Earnings Results

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Release

February 17, 20261 min read

Analysis

Halozyme Q4 2025 Earnings Surge: Royalty Revenue Soars 52%

Halozyme Therapeutics Inc. (NASDAQ: HALO) hit record revenue. Full-year 2025 revenue reached $1.4 billion. So this is 38% growth year-over-year....

February 17, 20262 min read

Halozyme Therapeutics, Inc (HALO) Q4 2025 Earnings Call

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Conference

February 10, 20261 min read

Halozyme Therapeutics, Inc (HALO) Q4 2025 Earnings Announcement

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q4 2025 Earnings Announcement

February 10, 20261 min read

Halozyme Therapeutics, Inc (HALO) Q2 2025 Earnings Call Transcript

Halozyme Therapeutics, Inc (NASDAQ: HALO) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Tram Bui — Head of Investor Relations Helen Torley —…

January 22, 202642 min read